Amgen must face lawsuit claiming it hid $10.7 billion tax bill

 A federal judge said Amgen (AMGN.O) must face a proposed class action accusing the drugmaker of waiting too long to tell shareholders it might owe the Internal Revenue Service $10.7 billion for underreporting six years of taxes.